Axogen, Inc. Gain (Loss) on Extinguishment of Debt
Axogen, Inc. (AXGN) reported Gain (Loss) on Extinguishment of Debt of -$16.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-07-29
- Axogen, Inc. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was $0.00.
- Axogen, Inc. gain (loss) on extinguishment of debt for the quarter ending 2026-03-31 was -$16.85M.
- Axogen, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00.
- Axogen, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-03-31 was $0.00.
- Axogen, Inc. gain (loss) on extinguishment of debt for fiscal 2020 was $0.00.
- Axogen, Inc. gain (loss) on extinguishment of debt for fiscal 2019 was $0.00.
- Axogen, Inc. gain (loss) on extinguishment of debt for fiscal 2018 was -$2.19M.
- Axogen, Inc. gain (loss) on extinguishment of debt for fiscal 2016 was -$750.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 3 month as first filed | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 6 month as first filed | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 9 month as first filed | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$16.85M 10-Q · filed 2026-07-29 | |||||
| 2026-03-31 | -$16.85M 10-Q · filed 2026-04-28 | ||||||
| 2025-06-30 | $0.00 10-Q · filed 2026-07-29 | $0.00 10-Q · filed 2026-07-29 | |||||
| 2025-03-31 | $0.00 10-Q · filed 2026-04-28 | ||||||
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | ||||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | -$2.19M derived: sum of 3 quarters · filed 2021-03-01 | -$2.19M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$2.19M derived: sum of 2 quarters · filed 2019-11-06 | -$2.19M 10-Q · filed 2019-11-06 | -$2.19M 10-Q · filed 2018-10-29 | |||
| 2018-06-30 | -$2.19M 10-Q · filed 2019-08-06 | -$2.19M 10-Q · filed 2018-08-01 | -$2.19M 10-Q · filed 2019-08-06 | -$2.19M 10-Q · filed 2018-08-01 | |||
| 2016-12-31 | -$750.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |